AR 2016

Upcoming:
our H1 results

Thursday 27 July, 22.00 CET

Conference call (+32 2 403 7297, code 4659682) & webcast on Friday 28 July, 14.00 CET

Register for webcast

Welcome to Galapagos

Galapagos is a clinical-stage biotechnology company, specialized in the discovery and development of small molecule medicines with novel modes of action. Our ambition is to become a leading global biotechnology company, focused on the development and commercialization of novel medicines that will improve people's lives. 

Learn more about Galapagos

News

Loading...

All Galapagos news

Events

Loading...

All Galapagos events

Current Openings

Loading...

All Current Openings